About Us
ACADIA Pharmaceuticals is a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders.
More »
News
November 09, 2009
ACADIA Pharmaceuticals Reports Third Quarter 2009 Financial Results
November 02, 2009
ACADIA Pharmaceuticals to Announce Third Quarter 2009 Financial Results on November 9, 2009
Product Candidates
We are focused on developing a portfolio consisting of four product candidates including pimavanserin, which is in Phase III development for the treatment of Parkinson's disease psychosis in collaboration with Biovail. In addition, we have a product candidate in Phase II for chronic pain and a product candidate in Phase I for glaucoma, both in collaboration with Allergan, and a program in IND-track development in collaboration with Meiji Seika.
Company Information
 |
Request Information » |
 |
Investor Webcasts » |
 |
Email Updates » |